INS and type 2 diabetes mellitus: Artemisinin and its derivatives also act on islet cells by promoting insulin secretion, protecting pancreatic islet ß cells, and achieving islet α-cell to ß-cell transdifferentiation by reversing a number of abnormal proteins and RNAs, thereby inhibiting the development and progression of T2DM.